Cargando…
Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients
BACKGROUND: While clinical guidelines recommend hepatocellular carcinoma (HCC) surveillance for at-risk individuals, reported surveillance rates in the United States and Europe remain disappointingly low. AIM: To quantify HCC surveillance in an Australian cohort, and assess for factors associated wi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713329/ https://www.ncbi.nlm.nih.gov/pubmed/35070048 http://dx.doi.org/10.4251/wjgo.v13.i12.2149 |
_version_ | 1784623747543597056 |
---|---|
author | Low, Elizabeth SL Apostolov, Ross Wong, Darren Lin, Sandra Kutaiba, Numan Grace, Josephine A Sinclair, Marie |
author_facet | Low, Elizabeth SL Apostolov, Ross Wong, Darren Lin, Sandra Kutaiba, Numan Grace, Josephine A Sinclair, Marie |
author_sort | Low, Elizabeth SL |
collection | PubMed |
description | BACKGROUND: While clinical guidelines recommend hepatocellular carcinoma (HCC) surveillance for at-risk individuals, reported surveillance rates in the United States and Europe remain disappointingly low. AIM: To quantify HCC surveillance in an Australian cohort, and assess for factors associated with surveillance underutilisation. METHODS: All patients undergoing HCC surveillance liver ultrasounds between January 1, 2018 to June 30, 2018 at a tertiary hospital in Melbourne, Australia, were followed until July 31, 2020, or when surveillance was no longer required. The primary outcome was the percentage of time up-to-date with HCC surveillance (PTUDS). Quantile regression was performed to determine the impact of factors associated with HCC surveillance underutilisation. RESULTS: Among 775 at-risk patients followed up for a median of 27.5 months, the median PTUDS was 84.2% (IQR: 66.3%-96.3%). 85.0% of patients were followed up by specialist gastroenterologists. Amongst those receiving specialist care, quantile regression demonstrated differential associations at various quantile levels of PTUDS for several factors. Older age at the 25(th )quantile (estimate 0.002 per percent, P = 0.03), and cirrhotic status at the 75(th )quantile (estimate 0.021, P = 0.017), were significantly associated with greater percentage of time up-to-date. African ethnicity (estimate -0.089, P = 0.048) and a culturally and linguistically diverse (CALD) background (estimate -0.063, P = 0.01) were significantly associated with lower PTUDS at the 50(th )quantile, and again for CALD at the 75(th )quantile (estimate -0.026, P = 0.045). CONCLUSION: While median PTUDS in this Australian cohort study was 84.2%, awareness of the impact of specific factors across PTUDS quantiles can aid targeted interventions towards improved HCC surveillance. |
format | Online Article Text |
id | pubmed-8713329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-87133292022-01-20 Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients Low, Elizabeth SL Apostolov, Ross Wong, Darren Lin, Sandra Kutaiba, Numan Grace, Josephine A Sinclair, Marie World J Gastrointest Oncol Retrospective Cohort Study BACKGROUND: While clinical guidelines recommend hepatocellular carcinoma (HCC) surveillance for at-risk individuals, reported surveillance rates in the United States and Europe remain disappointingly low. AIM: To quantify HCC surveillance in an Australian cohort, and assess for factors associated with surveillance underutilisation. METHODS: All patients undergoing HCC surveillance liver ultrasounds between January 1, 2018 to June 30, 2018 at a tertiary hospital in Melbourne, Australia, were followed until July 31, 2020, or when surveillance was no longer required. The primary outcome was the percentage of time up-to-date with HCC surveillance (PTUDS). Quantile regression was performed to determine the impact of factors associated with HCC surveillance underutilisation. RESULTS: Among 775 at-risk patients followed up for a median of 27.5 months, the median PTUDS was 84.2% (IQR: 66.3%-96.3%). 85.0% of patients were followed up by specialist gastroenterologists. Amongst those receiving specialist care, quantile regression demonstrated differential associations at various quantile levels of PTUDS for several factors. Older age at the 25(th )quantile (estimate 0.002 per percent, P = 0.03), and cirrhotic status at the 75(th )quantile (estimate 0.021, P = 0.017), were significantly associated with greater percentage of time up-to-date. African ethnicity (estimate -0.089, P = 0.048) and a culturally and linguistically diverse (CALD) background (estimate -0.063, P = 0.01) were significantly associated with lower PTUDS at the 50(th )quantile, and again for CALD at the 75(th )quantile (estimate -0.026, P = 0.045). CONCLUSION: While median PTUDS in this Australian cohort study was 84.2%, awareness of the impact of specific factors across PTUDS quantiles can aid targeted interventions towards improved HCC surveillance. Baishideng Publishing Group Inc 2021-12-15 2021-12-15 /pmc/articles/PMC8713329/ /pubmed/35070048 http://dx.doi.org/10.4251/wjgo.v13.i12.2149 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Retrospective Cohort Study Low, Elizabeth SL Apostolov, Ross Wong, Darren Lin, Sandra Kutaiba, Numan Grace, Josephine A Sinclair, Marie Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients |
title | Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients |
title_full | Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients |
title_fullStr | Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients |
title_full_unstemmed | Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients |
title_short | Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients |
title_sort | hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk australian patients |
topic | Retrospective Cohort Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713329/ https://www.ncbi.nlm.nih.gov/pubmed/35070048 http://dx.doi.org/10.4251/wjgo.v13.i12.2149 |
work_keys_str_mv | AT lowelizabethsl hepatocellularcarcinomasurveillanceandquantileregressionfordeterminantsofunderutilisationinatriskaustralianpatients AT apostolovross hepatocellularcarcinomasurveillanceandquantileregressionfordeterminantsofunderutilisationinatriskaustralianpatients AT wongdarren hepatocellularcarcinomasurveillanceandquantileregressionfordeterminantsofunderutilisationinatriskaustralianpatients AT linsandra hepatocellularcarcinomasurveillanceandquantileregressionfordeterminantsofunderutilisationinatriskaustralianpatients AT kutaibanuman hepatocellularcarcinomasurveillanceandquantileregressionfordeterminantsofunderutilisationinatriskaustralianpatients AT gracejosephinea hepatocellularcarcinomasurveillanceandquantileregressionfordeterminantsofunderutilisationinatriskaustralianpatients AT sinclairmarie hepatocellularcarcinomasurveillanceandquantileregressionfordeterminantsofunderutilisationinatriskaustralianpatients |